JP2005523891A5 - - Google Patents

Download PDF

Info

Publication number
JP2005523891A5
JP2005523891A5 JP2003561535A JP2003561535A JP2005523891A5 JP 2005523891 A5 JP2005523891 A5 JP 2005523891A5 JP 2003561535 A JP2003561535 A JP 2003561535A JP 2003561535 A JP2003561535 A JP 2003561535A JP 2005523891 A5 JP2005523891 A5 JP 2005523891A5
Authority
JP
Japan
Prior art keywords
autoimmunity
transplantation
seq
administering
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003561535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005523891A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001816 external-priority patent/WO2003061589A2/en
Publication of JP2005523891A publication Critical patent/JP2005523891A/ja
Publication of JP2005523891A5 publication Critical patent/JP2005523891A5/ja
Withdrawn legal-status Critical Current

Links

JP2003561535A 2002-01-23 2003-01-23 ペプチド構築物を用いる疾患もしくは状態の治療方法 Withdrawn JP2005523891A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34998202P 2002-01-23 2002-01-23
US34998302P 2002-01-23 2002-01-23
US35003202P 2002-01-23 2002-01-23
PCT/US2003/001816 WO2003061589A2 (en) 2002-01-23 2003-01-23 Methods for treating diseases or conditions with peptide constructs

Publications (2)

Publication Number Publication Date
JP2005523891A JP2005523891A (ja) 2005-08-11
JP2005523891A5 true JP2005523891A5 (https=) 2006-03-09

Family

ID=27617581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561535A Withdrawn JP2005523891A (ja) 2002-01-23 2003-01-23 ペプチド構築物を用いる疾患もしくは状態の治療方法

Country Status (5)

Country Link
US (1) US20070003542A1 (https=)
EP (1) EP1485466A4 (https=)
JP (1) JP2005523891A (https=)
AU (1) AU2003237493A1 (https=)
WO (1) WO2003061589A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005529065A (ja) * 2002-01-23 2005-09-29 セル−サイ・コーポレーシヨン 疾患を治療するためのペプチド構築物
US8034773B2 (en) * 2004-02-05 2011-10-11 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US8178649B2 (en) * 2004-12-07 2012-05-15 Arizona Biomedical Research Commission Immunostimulatory compositions and uses thereof
US7811995B2 (en) * 2006-12-13 2010-10-12 Susavion Biosciences, Inc. Therapeutic and diagnostic peptides
US8496942B2 (en) * 2006-12-13 2013-07-30 Susavion Biosciences, Inc. Therapeutic peptides and uses thereof
WO2010085661A1 (en) * 2009-01-23 2010-07-29 Musc Foundation For Reasearch Development Modified peptides and their use
WO2014165164A2 (en) * 2013-03-12 2014-10-09 Albany Medical College Compositions and methods for treating autoimmune diseases
JP6740250B2 (ja) 2015-04-27 2020-08-12 スサヴィオン バイオサイエンシーズ インコーポレイテッド がんおよび持続性ウイルス感染を処置するための組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106840A (en) * 1988-06-23 2000-08-22 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
US6224870B1 (en) * 1997-01-24 2001-05-01 Genitrix, Ltd. Vaccine compositions and methods of modulating immune responses
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
EP1030819A4 (en) * 1997-09-30 2001-11-21 Cel Sci Corp CONJUGATED IMMUNOGENIC POLYPEPTIDE FOR THE TREATMENT OF HERPES SIMPLEX VIRUS
WO2001036448A2 (en) * 1999-10-27 2001-05-25 Cel-Sci Corporation Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
AU4705201A (en) * 1999-10-27 2001-06-25 Cel-Sci Corporation Peptide constructs for treating autoimmune and related diseases
US6951647B2 (en) * 2001-05-24 2005-10-04 Cel-Sci Corporation T cell binding ligand peptides and method of inducing a cellular immune response
JP2005529065A (ja) * 2002-01-23 2005-09-29 セル−サイ・コーポレーシヨン 疾患を治療するためのペプチド構築物

Similar Documents

Publication Publication Date Title
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
JP2003509343A5 (https=)
JP2005537234A5 (https=)
NO20053126D0 (no) Kontrollsystem for medisinsk behandling.
NL1027833A1 (nl) Verbindingen bruikbaar bij therapie.
CL2007003472A1 (es) Sal fumarato de (alfa s,beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol; proceso de preparacion; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamie
JP2006514116A5 (https=)
WO2005030928A3 (en) PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
WO2007044396A3 (en) Fibronectin polypeptides and methods of use
DE60332663D1 (de) CCR1-Rezeptor-Antagonisten zur Behandlung u.a. Demyelinisierender entzündlicher Erkrankungen
ATE538811T1 (de) Zytotoxizitätsvermittlung von zellen mit hinweisen auf oberflächenexpression von cd44
JP2005523891A5 (https=)
JP2004534810A5 (https=)
DE602004010643D1 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
WO2005086825A3 (en) Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
FR2912404B1 (fr) Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
DE69939212D1 (de) Polypeptid mit aktivität gegen das humane immundefizienz virus, dafür kodierende gene und verfahren zur herstellung des polypeptids
JP2005506959A5 (https=)
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
RU2002135207A (ru) Средство "арголит" для лечения инфицированных ран
RU2005119153A (ru) Средство лечения острой лучевой болезни
JP2007517775A5 (https=)
JP2006514072A5 (https=)